Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omarigliptin Real-World Evaluation in Bangladesh
NCT06449235Phase 4Not yet recruiting
- Start
- Sep 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omarigliptin in type 2 diabetes mellitus (T2DM). Planned start Sep 2024; status: not yet recruiting.
02
Drugs
omarigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06449235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06449235.